Carmine Therapeutics, Inc. — Form D
Carmine Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-29. The offering totals $13.7M, of which $13.7M was reported sold. Industry: Other.
Offering
- Filed: 2022-11-29
- Form: D
- Accession: 0001948053-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $13.7M
- Amount sold: $13.7M
- Investors: 6
- Date of first sale: 2022-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466061
Issuer
- Name: Carmine Therapeutics, Inc.
- CIK: 0001948053
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 150 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA, 02140
- Phone: 978-289-7076
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Elan Ezickson | Director | Cambridge, MA |
| Donald Haut | Director | Cambridge, MA |
| Harvey Lodish | Director | Cambridge, MA |
| Lin Xiangqian | Director | Cambridge, MA |
| Donald Haut | Executive Officer | Cambridge, MA |
More